Status:
UNKNOWN
The Effects of Covid-19 Pandemic on The Patients With Fibromyalgia
Lead Sponsor:
Diskapi Yildirim Beyazit Education and Research Hospital
Conditions:
Fibromyalgia
Covid-19 Fear
Eligibility:
All Genders
18-65 years
Brief Summary
The investigators planned to analyze the effect of Covid-19 fear and anxiety on the daily life, sleep quality and depression-anxiety levels of fibromyalgia patients.
Detailed Description
Fibromyalgia; as a chronic syndrome of unknown cause with widespread body pain, fatigue, sleep disorder, cognitive impairment and anxiety. Many studies have shown a relationship between pain levels an...
Eligibility Criteria
Inclusion
- Inclusion Criteria (Fibromyalgia group):
- Patients diagnosed as Fibromyalgia syndrome according to American College of Rheumatology over 1 year
- Patients' disease activity is stabil at least 3 months Inclusion Criteria (Control group) Patients have no physicologic or severe musculoskeletal and rheumatologic diseases
- Exclusion Criteria:
- Patients with having other modd disorders
- Patients with severe musculoskeletal diseases
- Patients with other rheumatologic diseases
Exclusion
Key Trial Info
Start Date :
December 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 28 2021
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04686578
Start Date
December 1 2020
End Date
February 28 2021
Last Update
February 3 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Diskapi Education and Research Hospital
Ankara, Altındag, Turkey (Türkiye), 06300